Alcon Inc.
Company & revenue
About Alcon Inc.
Who they are
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures.
Detailed revenue, brand and relationship research has not yet been completed for ALC.
Wall Street Score
Overall investment score · Quality, value, risk and opportunity
35
Poor
View category scores →
Company Quality
How good is the actual business—regardless of today’s stock price?
60
Fair
Financial Strength
66
Business Quality / Moat
68
Management
53
Growth Quality
36
Risk / Durability
76
Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.
Opportunity
Opportunity Score · How does the current price compare with estimated value?
25
Avoid
Based on current valuation, company quality, recent trends, and available market signals.
View score details →
Model Outlook
12-month model · What does the model think happens next?
35/100
Building Historical Record
Model Score 35/100 — estimates relative performance potential, distinct from WallStreetScore (company quality).
Probability unavailable — the model has not produced a calibrated probability yet.
Click for full breakdown →
WSS View
The quick read
WSS currently sees meaningful weaknesses in the company-strength profile.
At today’s price, the WSS valuation framework currently reads as less attractive based on the available valuation and market data.
The model outlook is currently cautious.
- •Balance-sheet / debt profile scores strongly
- •Recent buyback activity is present
- •Valuation is a weaker part of the current profile
- •Revenue fundamentals are weak
- •Asset quality is a weaker factor
Company-specific research
Questions worth answering for ALC
These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.
- •Can ALC maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
- •Is ALC's positive free cash flow repeatable, or is the current level being helped by temporary working-capital or spending changes?
- •Is ALC's debt load manageable relative to cash generation, interest costs and upcoming maturities?
- •What future growth or profitability would be needed to justify ALC's current valuation?
- •What does the current fundamental change risk warning mean for the reliability or interpretation of ALC's score?
Essential Investment Snapshot
Wall Street Score
35
Opportunity Score
25
Market Cap
$31.10B
P/E Ratio
49.8
EPS
$1.30
52-Week High
$87.64
52-Week Low
$61.84
Beta
0.70
Intrinsic Value
$26.82
Analyst Target
$80.50
Shares Outstanding
496.2M
Total Revenue
$10.81B
Total Debt
$5.30B
Dividend Yield
0.56%
Liquidation Value / Share
$43.52
Annual Dividend
$0.36
Momentum & Volatility Signals
Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.
Strong downward momentum
Low movement
A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.
A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.
Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.
Notices for ALC
Detected from reported data — verify before acting.Dividend history reported
Dividend payments are recorded. Review the dates and regular/special classification below; past payments do not guarantee future dividends.
Historical repurchase activity
Reported cash flows or share-count measures indicate past repurchase activity. This does not verify an active buyback authorization or future purchases.
Community Sentiment
0 active · 0 total callsNo personal call yet on ALC.
What the Bulls Say
- +Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
- +Product opportunity: Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables.
- +Product opportunity: and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company’s cataract products include Unity CS, LenSx laser system, Veri.
- +Positive free cash flow may provide capacity to invest in growth.
What the Bears Say
- −Key risks may include competition, margin pressure, debt levels, valuation risk, and changes in demand within the Medical - Specialties industry.
Bull and bear cases summarize disclosed catalysts, growth opportunities and risks; they are not buy or sell recommendations.
Create a free account to make a call.
Scores
Click any score for full breakdownWas this stock page easy to understand?
One click helps us improve the research experience. This is not tied to an investment decision.
Score Changes
5 historical score records availablePrevious Score
34
Sep 8, 2026
Change
+0.8
points
Current Score
35
Oct 1, 2026
Category Changes
ALC increased 0.8 points because Valuation improved by 4.4 points.
Positive Contributors
- + Valuation improved by 4.4 points
Projected Score
Projected Score
30
Projected Change
-4.8%
Preliminary comparable-period financial changes suggest decline of approximately 4.8 points. This is a projected estimate, not the official WallStreetScore.
Price vs. Value
OvervaluedCurrent Price
$63.76
Intrinsic Value
$26.82
Difference
+$36.94
+137.8% vs IV
Margin of Safety
-137.8%
Related Companies
Medical - SpecialtiesNews
Is it a Prudent Move to Retain ALC Stock in Your Portfolio Now?
Alcon: A Re-Rating In Eyesight
Alcon Launches UNITY M, a Premium Ophthalmic Microscope Delivering Precise Control
Alcon Prices EUR 500 Million Senior Notes Offering
Related Stock Research
Continue researching this company with related Wall Street Score rankings and investing guides.
Score Alerts
Premium unlocks alerts when a score rises, falls, or reaches your target price.
Start 7-Day Free TrialPortfolio Score
Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.
Start 7-Day Free Trial